Biogen BIIB
NASDAQ BIIB
$253.84 +12.86 (+5.34%)
At close: Oct 22, 2026 · 4:00 PM EDT

Biogen (BIIB) Short-Term Debt repayments (2010 - 2011)

Updated

Biogen (BIIB) recorded Short-Term Debt repayments of $2.43 million in FY2012, down 78.8% from $11.46 million in FY2011.

Analysis

Biogen (BIIB) Short-Term Debt repayments (2010 - 2011) Analysis & Trends

Starting with FY2009, Biogen's Short-Term Debt repayments history includes 4 years.

  • Annual Short-Term Debt repayments has a three-year compound annual growth rate of -39.3% (FY2009 to FY2012).
  • Per Business Quant data, BIIB's Short-Term Debt repayments was $11.46 million in FY2011 (-36.6%), $18.07 million in FY2010 (+66.3%) and $10.87 million in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 6.63 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Biogen 37.51 Bn 24.16 Bn 1.96 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 -1,000.00
Sep 30, 2011 4.21 Mn
Jun 30, 2011 5.14 Mn
Mar 31, 2011 2.11 Mn
Dec 31, 2010 1.89 Mn
Sep 30, 2010 2.04 Mn
Jun 30, 2010 12.13 Mn
Mar 31, 2010 2.01 Mn
API Access

Biogen Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=BIIB&period=max&api_key=YOUR_API_KEY